E2F8 as a Novel Therapeutic Target for Lung Cancer

Volume: 107, Issue: 9
Published: Jun 18, 2015
Abstract
The E2F members have been divided into transcription activators (E2F1-E2F3) and repressors (E2F4-E2F8). E2F8 with E2F7 has been known to play an important physiologic role in embryonic development and cell cycle regulation by repressing E2F1. However, the function of E2F8 in cancer cells is unknown.E2F8 expression was assessed by immunoblotting or immunofluorescence staining in human lung cancer (LC) cells and tissues from LC patients (n = 45)....
Paper Details
Title
E2F8 as a Novel Therapeutic Target for Lung Cancer
Published Date
Jun 18, 2015
Volume
107
Issue
9
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.